
Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …

The University of Sussex is set to produce a portfolio of new cancer drugs which exploit our DNA damage response …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

